A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 60
- Registration Number
- NCT06745284
A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated
- Conditions
- Interventions
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 124
- Registration Number
- NCT06745297
- Locations
- 🇩🇪
Charité Research Organisation GmbH, Berlin, Germany
A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy
- Conditions
- Interventions
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 180
- Registration Number
- NCT06722157
- Locations
- 🇺🇸
Associated Retina Consultants, Gilbert, Arizona, United States
🇺🇸Associated Retina Consultants, Ltd., Phoenix, Arizona, United States
🇺🇸Phoenix Retina Associates, Phoenix, Arizona, United States
A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People
- Conditions
- Interventions
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 40
- Registration Number
- NCT06716190
- Locations
- 🇧🇪
SGS Life Science Services - Clinical Research, Edegem, Belgium
A Study to Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems
- First Posted Date
- 2024-11-18
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 32
- Registration Number
- NCT06692322
A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH
- Conditions
- Interventions
- First Posted Date
- 2024-11-05
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 24
- Registration Number
- NCT06675929
- Locations
- 🇺🇸
Southern California Research Center, Coronado, California, United States
🇺🇸Catalina Research Institute, LLC-Montclair-49051, Montclair, California, United States
🇺🇸Inland Empire Clinical Trials, LLC, Rialto, California, United States
A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the Body
- Conditions
- Interventions
- First Posted Date
- 2024-10-23
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 14
- Registration Number
- NCT06655220
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood
- Conditions
- Interventions
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 15
- Registration Number
- NCT06647810
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Conditions
- Interventions
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 40
- Registration Number
- NCT06636656
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Conditions
- Interventions
- First Posted Date
- 2024-10-09
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1800
- Registration Number
- NCT06632444
- Locations
- 🇺🇸
ARK Clinical Research, Long Beach, California, United States
🇺🇸Clinnova Research Solutions, Orange, California, United States
🇺🇸Entrust Clinical Research, Miami, Florida, United States